These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32006156)

  • 21. Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).
    Leonardi S; Franzone A; Piccolo R; McFadden E; Vranckx P; Serruys P; Benit E; Liebetrau C; Janssens L; Ferrario M; Zurakowski A; van Geuns RJ; Dominici M; Huber K; Slagboom T; Buszman P; Bolognese L; Tumscitz C; Bryniarski K; Aminian A; Vrolix M; Petrov I; Garg S; Naber C; Prokopczuk J; Hamm C; Steg G; Heg D; Juni P; Windecker S; Valgimigli M
    BMJ Open; 2019 Mar; 9(3):e026053. PubMed ID: 30852547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial.
    Vranckx P; Valgimigli M; Windecker S; Steg PG; Hamm C; Jüni P; Garcia-Garcia HM; van Es GA; Serruys PW
    EuroIntervention; 2016 Nov; 12(10):1239-1245. PubMed ID: 26606735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS Trial.
    Vranckx P; Valgimigli M; Odutayo A; Serruys PW; Hamm C; Steg PG; Heg D; Mc Fadden EP; Onuma Y; Benit E; Janssens L; Diletti R; Ferrario M; Huber K; Räber L; Windecker S; Jüni P;
    J Am Heart Assoc; 2021 Sep; 10(18):e015560. PubMed ID: 34533034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events.
    Hara H; van Klaveren D; Takahashi K; Kogame N; Chichareon P; Modolo R; Tomaniak M; Ono M; Kawashima H; Wang R; Gao C; Niethammer M; Fontos G; Angioi M; Ribeiro VG; Barbato E; Leandro S; Hamm C; Valgimigli M; Windecker S; Jüni P; Steg PG; Verbeeck J; Tijssen JGP; Sharif F; Onuma Y; Serruys PW;
    Circ Cardiovasc Qual Outcomes; 2020 Aug; 13(8):e006660. PubMed ID: 32762446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of one-month DAPT followed by 23-month ticagrelor monotherapy in patients undergoing proximal LAD stenting: Insights from the GLOBAL LEADERS trial.
    Takahashi K; Wang R; Kawashima H; Tomaniak M; Gao C; Ono M; Hara H; Wykrzykowska JJ; de Winter RJ; Werner N; Teiger E; Almeida M; Barraud P; Lantelme P; Barlis P; Garg S; Hamm C; Steg PG; Onuma Y; Vranckx P; Windecker S; Valgimigli M; Serruys PW
    Int J Cardiol; 2020 Dec; 320():27-34. PubMed ID: 32750393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting.
    Franzone A; McFadden E; Leonardi S; Piccolo R; Vranckx P; Serruys PW; Benit E; Liebetrau C; Janssens L; Ferrario M; Zurakowski A; Diletti R; Dominici M; Huber K; Slagboom T; Buszman P; Bolognese L; Tumscitz C; Bryniarski K; Aminian A; Vrolix M; Petrov I; Garg S; Naber C; Prokopczuk J; Hamm C; Steg PG; Heg D; Jüni P; Windecker S; Valgimigli M;
    J Am Coll Cardiol; 2019 Nov; 74(18):2223-2234. PubMed ID: 31672177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of established cardiovascular disease on outcomes in the randomized global leaders trial.
    Garg S; Chichareon P; Kogame N; Takahashi K; Modolo R; Chang CC; Tomaniak M; Fath-Ordoubadi F; Anderson R; Oldroyd KG; Stables RH; Kukreja N; Chowdhary S; Galasko G; Hoole S; Zaman A; Hamm CW; Steg PG; Jüni P; Valgimigli M; Windecker S; Onuma Y; Serruys PW
    Catheter Cardiovasc Interv; 2020 Dec; 96(7):1369-1378. PubMed ID: 31854112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial.
    Ono M; Hara H; Kawashima H; Gao C; Wang R; Wykrzykowska JJ; Piek JJ; Garg S; Hamm C; Steg PG; Valgimigli M; Windecker S; Vranckx P; Onuma Y; Serruys PW
    EuroIntervention; 2022 Aug; 18(5):e377-e388. PubMed ID: 35260381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of white blood cell count on clinical outcomes in patients treated with aspirin-free ticagrelor monotherapy after percutaneous coronary intervention: insights from the GLOBAL LEADERS trial.
    Ono M; Tomaniak M; Koenig W; Khamis R; de Silva R; Chichareon P; Kawashima H; Hara H; Gao C; Wang R; Huber K; Vrolix M; Jasionowicz P; Wykrzykowska JJ; Piek JJ; Jüni P; Hamm C; Steg PG; Windecker S; Onuma Y; Storey RF; Serruys PW
    Eur Heart J Cardiovasc Pharmacother; 2022 Jan; 8(1):39-47. PubMed ID: 32956446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
    D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
    Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.
    Camaro C; Damen SA; Brouwer MA; Kedhi E; Lee SW; Verdoia M; Barbieri L; Rognoni A; van T Hof AW; Ligtenberg E; de Boer MJ; Suryapranata H; De Luca G
    Am Heart J; 2016 Aug; 178():37-44. PubMed ID: 27502850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index.
    Kunadian V; Baber U; Pivato CA; Cao D; Dangas G; Sartori S; Zhang Z; Angiolillo DJ; Briguori C; Cohen DJ; Collier T; Dudek D; Gibson M; Gil R; Huber K; Kaul U; Kornowski R; Krucoff MW; Dehghani P; Mehta S; Moliterno DJ; Ohman EM; Escaned J; Sardella G; Sharma SK; Shlofmitz R; Weisz G; Witzenbichler B; Džavík V; Gurbel P; Hamm CW; Henry T; Kastrati A; Marx SO; Oldroyd K; Steg PG; Pocock S; Mehran R
    JACC Cardiovasc Interv; 2022 Oct; 15(19):1948-1960. PubMed ID: 36202563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study.
    Baber U; Dangas G; Cohen DJ; Gibson CM; Mehta SR; Angiolillo DJ; Pocock SJ; Krucoff MW; Kastrati A; Ohman EM; Steg PG; Badimon J; Zafar MU; Chandrasekhar J; Sartori S; Aquino M; Mehran R
    Am Heart J; 2016 Dec; 182():125-134. PubMed ID: 27914492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.
    Costa F; Vranckx P; Leonardi S; Moscarella E; Ando G; Calabro P; Oreto G; Zijlstra F; Valgimigli M
    Eur Heart J; 2015 May; 36(20):1242-51. PubMed ID: 25718355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional variation in patients and outcomes in the GLOBAL LEADERS trial.
    Gao C; Takahashi K; Garg S; Hara H; Wang R; Kawashima H; Ono M; Montalescot G; Haude M; Slagboom T; Vranckx P; Valgimigli M; Windecker S; Hamm C; Steg PG; Storey R; van Geuns RJ; Tao L; Onuma Y; Serruys PW
    Int J Cardiol; 2021 Feb; 324():30-37. PubMed ID: 32941872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial.
    Serruys PW; Tomaniak M; Chichareon P; Modolo R; Kogame N; Takahashi K; Chang CC; Spitzer E; Walsh SJ; Adlam D; Hildick-Smith D; Édes I; van de Harst P; Krackhardt F; Tijssen JGP; Rademaker-Havinga T; Garg S; Steg PG; Hamm C; Jüni P; Vranckx P; Onuma Y; Verheugt FWA
    EuroIntervention; 2019 Dec; 15(12):e1090-e1098. PubMed ID: 30888959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Percutaneous Coronary Intervention: From the STOPDAPT-2 Total Cohort.
    Obayashi Y; Watanabe H; Morimoto T; Yamamoto K; Natsuaki M; Domei T; Yamaji K; Suwa S; Isawa T; Watanabe H; Yoshida R; Sakamoto H; Akao M; Hata Y; Morishima I; Tokuyama H; Yagi M; Suzuki H; Wakabayashi K; Suematsu N; Inada T; Tamura T; Okayama H; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Morino Y; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
    Circ Cardiovasc Interv; 2022 Aug; 15(8):e012004. PubMed ID: 35912647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
    Gelbenegger G; Schoergenhofer C; Jilma B; Gager GM; Dizdarevic AM; Mamas MA; Parapid B; Velagapudi P; Siller-Matula JM
    Clin Pharmacol Ther; 2021 Aug; 110(2):424-431. PubMed ID: 33668076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex Differences in Outcomes of Ticagrelor Therapy With or Without Aspirin After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Secondary Analysis of the TICO Randomized Clinical Trial.
    Lee B; Lee SJ; Kim BK; Lee YJ; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):e218-e226. PubMed ID: 37021576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial.
    Krucoff M; Spirito A; Baber U; Sartori S; Angiolillo DJ; Briguori C; Cohen DJ; Collier T; Dangas G; Dudek D; Escaned J; Gibson CM; Han YL; Huber K; Kastrati A; Kaul U; Kornowski R; Kunadian V; Vogel B; Mehta SR; Moliterno D; Sardella G; Shlofmitz RA; Sharma S; Steg PG; Pocock S; Mehran R
    Am Heart J; 2024 Jun; 272():11-22. PubMed ID: 38458371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.